Lobbyradar DE
Organisation · Unternehmen

Novo Nordisk A/S

novo-nordisk-as-eutr-31332911

Aussagen (8)

eu transparency category
Companies & groups
dokumentiert [Q-21669]
eu transparency goals
Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to serious chronic diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure the diseases we treat. We employ more than 60,000 people in 80 countries, and market our products in 170 countries. In 2023, we served more than 40 million patients worldwide. In 2023, we served more than 6 million patients in the EU. More than 30,000 of our employees are based in the EU. Novo Nordisk is committed to developing its business towards environmental, social and financial sustainability (the triple bottom line).The controlling stake in Novo Nordisk is owned by the Novo Nordisk Foundation. This is a non-profit institution, whose formal purpose is to provide a stable basis for its companies’ operations and to make contributions to scientific, humanitarian and social progress.
dokumentiert [Q-21669]
eu transparency id
29570313329-11
dokumentiert [Q-7535]
headquarters city
Bagsværd
dokumentiert [Q-21669]
headquarters country
DE
dokumentiert [Q-21669]
interest class
business_company
dokumentiert [Q-29773]
legal form
Corporation
dokumentiert [Q-21669]
legal form class
ausland_sonstig
berichtet [Q-29773]